You are here: Welcome » Robyn Harrison

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision
Previous revision
Both sides next revision
robyn_harrison [2022/03/29 16:24]
liam [National Advisory Committee on Immunization (2017-current)]
robyn_harrison [2022/03/29 16:58] (current)
liam [COVID-19]
Line 49: Line 49:
 ==== Antimicrobial Resistance ==== ==== Antimicrobial Resistance ====
  
-Dr. Harrison is an Editorial Contributor/Reviewer for an antimicrobial resistance project called Bugs & Drugs. Other team members include:+Dr. Harrison is an Editorial Contributor/Reviewer for an [[antimicrobial resistance]] project called [[Bugs & Drugs]].((//B&D - The App.// Bugs and Drugs. Retrieved March 24, 2022, from https://archive.ph/h9lq7)) Other team members include:
  
-  * John Conly of the AHS Scientific Advisory Group for COVID-19  +  * [[public_health_agencies:canada:John Conly of the AHS Scientific Advisory Group for COVID-19  
-  * Andrew Morris of the Ontario COVID-19 Science Advisory Table +  * [[public_health_agencies:canada:Andrew Morris]] of the [[Ontario COVID-19 Science Advisory Table]] 
-  * Lynora Saxinger of the AHS Scientific Advisory Group for COVID-19+  * [[public_health_agencies:canada:Lynora Saxinger]] of the AHS Scientific Advisory Group for COVID-19
  
-The project was funded by Alberta Health Services, Alberta Health, and the BC Ministry of Health, Pharmaceutical Services Division.+The project was funded by [[public_health_agencies:canada:Alberta Health Services]][[Alberta Health]], and the [[BC Ministry of Health]], Pharmaceutical Services Division.
  
 ==== COVID-19 ==== ==== COVID-19 ====
  
-Dr. Harrison is a site investigator for Canadian COVID-19 Cohort Study (CCCS), studying the epidemiology of COVID-19 in Canadian healthcare workers. The specific items for research include the rate of COVID-19 infection, risk factors for infection (occupational and community), antibody levels over time, uptake of vaccines against COVID-19, and psychological impact of working during a pandemic. Dr. Harrison’s study group includes staff working at either Grey Nuns Community Hospital or the University of Alberta Hospital.+Dr. Harrison is a site investigator for [[Canadian COVID-19 Cohort Study]] (CCCS), studying the epidemiology of [[COVID-19]] in Canadian healthcare workers.((//Edmonton - Canadian COVID-19 Cohort Study (CCCS): Study of the epidemiology of COVID-19 in Canadian healthcare workers.// TIBDN: Toronto Invasive Bacterial Diseases Network. Retrieved March 21, 2022, from https://archive.ph/3u0sv)) The specific items for research include the rate of COVID-19 infection, risk factors for infection (occupational and community), antibody levels over time, uptake of [[vaccines]] against COVID-19, and psychological impact of working during a [[pandemic]]. Dr. Harrison’s study group includes staff working at either [[Grey Nuns Community Hospital]] or the [[University of Alberta Hospital]].
  
-The CCCS study page bearing Dr. Harrison’s name is hosted on the website for the Toronto Invasive Bacterial Diseases Network at Mount Sinai Hospital, which is funded by “an unrestricted educational grant from Pfizer Canada Inc.”+The CCCS study page bearing Dr. Harrison’s name is hosted on the website for the [[Toronto Invasive Bacterial Diseases Network]] at [[Mount Sinai Hospital]], which is funded by “an unrestricted educational grant from [[pharmaceutical_companies:Pfizer|Pfizer Canada Inc]].”
  
Back to top